Filings under DERM by Dermira, Inc. (CIK 0001557883) from Oct 2, 2014 to Feb 20, 2020 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Herskowitz Neil | Director | Grant(A) | 50K | — | $0 |
| Jul 1, 2026 | Smith Justin Adam | Director | Grant(A) | 50K | — | $0 |
| Jul 1, 2026 | Toledano Miranda Jayne | Director | Grant(A) | 50K | — | $0 |
| Jun 25, 2026 | Smith Justin Adam | Director | Grant(A) | 10K | — | $0 |
| Jun 25, 2026 | Herskowitz Neil | Director | Grant(A) | 10K | — | $0 |
| Jun 25, 2026 | Pearce Michael Cooper | Director | Grant(A) | 10K | — | $0 |
| Jun 25, 2026 | Rosenwald Lindsay A MD | Director | Grant(A) | 10K | — | $0 |
| Jun 25, 2026 | Toledano Miranda Jayne | Director | Grant(A) | 10K | — | $0 |
| Apr 22, 2026 | Maraoui Claude | President & CEO, Director | Grant(A) | 49K | — | $0 |
| Apr 22, 2026 | Maraoui Claude | President & CEO, Director | Grant(A) | 83K | — | $0 |
| Apr 22, 2026 | Alloush Ramsey | Chief Operating Officer | Grant(A) | 47K | — | $0 |
| Apr 22, 2026 | Alloush Ramsey | Chief Operating Officer | Grant(A) | 63K | — | $0 |
| Apr 22, 2026 | Benesch Joseph | CFO | Grant(A) | 29K | — | $0 |
| Apr 22, 2026 | Benesch Joseph | CFO | Grant(A) | 42K | — | $0 |
| Aug 25, 2025 | Maraoui Claude | President & CEO, Director | Option exercise(M) | 1.3M | $0.07 | $88K |
| Aug 25, 2025 | Maraoui Claude | President & CEO, Director | Tax withholding(F) | 11K | $7.47 | $81K |
| Aug 25, 2025 | Maraoui Claude | President & CEO, Director | Option exercise(M) | 1.3M | — | $0 |
| Aug 5, 2025 | Herskowitz Neil | Director | Grant(A) | 20K | — | $0 |
| Aug 5, 2025 | Pearce Michael Cooper | Director | Grant(A) | 20K | — | $0 |
| Aug 5, 2025 | Toledano Miranda Jayne | Director | Grant(A) | 20K | — | $0 |
| Aug 5, 2025 | Smith Justin Adam | Director | Grant(A) | 20K | — | $0 |
| Aug 5, 2025 | Rosenwald Lindsay A MD | Director | Grant(A) | 50K | — | $0 |
| Jun 25, 2025 | Herskowitz Neil | Director | Grant(A) | 7K | — | $0 |
| Jun 25, 2025 | Smith Justin Adam | Director | Grant(A) | 7K | — | $0 |
| Jun 25, 2025 | Pearce Michael Cooper | Director | Grant(A) | 7K | — | $0 |
| Jun 25, 2025 | Rosenwald Lindsay A MD | Director | Grant(A) | 7K | — | $0 |
| Jun 25, 2025 | Toledano Miranda Jayne | Director | Grant(A) | 7K | — | $0 |
| Jun 17, 2025 | Maraoui Claude | President & CEO, Director | Grant(A) | 49K | — | $0 |
| Jun 17, 2025 | Maraoui Claude | President & CEO, Director | Grant(A) | 83K | — | $0 |
| Jun 17, 2025 | Benesch Joseph | CFO | Grant(A) | 29K | — | $0 |
| Jun 17, 2025 | Benesch Joseph | CFO | Grant(A) | 42K | — | $0 |
| Jun 17, 2025 | Alloush Ramsey | Chief Operating Officer | Grant(A) | 47K | — | $0 |
| Jun 17, 2025 | Alloush Ramsey | Chief Operating Officer | Grant(A) | 63K | — | $0 |
| May 2, 2025 | Alloush Ramsey | COO | Sell(S) | 3K | $6.84 | $20K |
| May 2, 2025 | Benesch Joseph | CFO | Sell(S) | 2K | $6.84 | $16K |
| May 2, 2025 | Maraoui Claude | President & CEO, Director | Sell(S) | 5K | $6.84 | $33K |
| Mar 11, 2025 | Maraoui Claude | President & CEO, Director | Sell(S) | 49K | $5.01 | $247K |
| Mar 7, 2025 | Maraoui Claude | President & CEO, Director | Sell(S) | 15K | $5.01 | $75K |
| Mar 6, 2025 | Maraoui Claude | President & CEO, Director | Sell(S) | 26K | $5.04 | $129K |
| Mar 5, 2025 | Maraoui Claude | President & CEO, Director | Sell(S) | 18K | $5.13 | $93K |
| Mar 4, 2025 | Maraoui Claude | President & CEO, Director | Sell(S) | 29K | $5.04 | $146K |
| Mar 3, 2025 | Maraoui Claude | President & CEO, Director | Sell(S) | 24K | $5.19 | $122K |
| Feb 21, 2025 | Benesch Joseph | CFO | Sell(S) | 1K | $5.19 | $7K |
| Aug 1, 2024 | Benesch Joseph | CFO | Sell(S) | 9K | $5.47 | $51K |
| Jul 23, 2024 | Benesch Joseph | CFO | Sell(S) | 4K | $5.40 | $22K |
| Jul 19, 2024 | Pearce Michael Cooper | Director | Grant(A) | 30K | — | $0 |
| Jul 8, 2024 | Rosenwald Lindsay A MD | Director | Grant(A) | 10K | — | $0 |
| Jul 8, 2024 | Toledano Miranda Jayne | Director | Grant(A) | 10K | — | $0 |
| Jul 8, 2024 | Herskowitz Neil | Director | Grant(A) | 10K | — | $0 |
| Jul 8, 2024 | Smith Justin Adam | Director | Grant(A) | 10K | — | $0 |
| May 1, 2024 | Benesch Joseph | CFO | Grant(A) | 80K | — | $0 |
| May 1, 2024 | Maraoui Claude | President & CEO, Director | Grant(A) | 175K | — | $0 |
| Mar 25, 2024 | Rosenwald Lindsay A MD | Director | Buy(P) | 10K | $3.04 | $30K |
| Mar 22, 2024 | Rosenwald Lindsay A MD | Director | Buy(P) | 20K | $3.40 | $68K |
| Mar 22, 2024 | Smith Justin Adam | Director | Buy(P) | 30K | $3.47 | $104K |
| Mar 22, 2024 | Maraoui Claude | President & CEO, Director | Buy(P) | 10K | $3.48 | $35K |
| Feb 22, 2024 | Benesch Joseph | Interim CFO | Sell(S) | 2K | $3.75 | $9K |
| Jan 3, 2024 | Benesch Joseph | CFO | Grant(A) | 80K | — | $0 |
| Jan 3, 2024 | Maraoui Claude | President & CEO, Director | Grant(A) | 175K | — | $0 |
| Nov 28, 2023 | Paley Jeffrey | Director | Sell(S) | 2K | $5.22 | $9K |
| Nov 8, 2023 | Paley Jeffrey | Director | Sell(S) | 255 | $3.76 | $959 |
| Nov 7, 2023 | Paley Jeffrey | Director | Sell(S) | 2K | $3.48 | $8K |
| Oct 13, 2023 | Smith Justin Adam | Director | Buy(P) | 33K | $2.98 | $98K |
| Oct 6, 2023 | Paley Jeffrey | Director | Buy(P) | 15K | $2.98 | $45K |
| Sep 21, 2023 | Paley Jeffrey | Director | Buy(P) | 30K | $2.97 | $89K |
| Sep 6, 2023 | Rosenwald Lindsay A MD | Director | Buy(P) | 100K | $2.23 | $223K |
| Sep 6, 2023 | Maraoui Claude | President & CEO, Director | Buy(P) | 26K | $2.52 | $66K |
| Jul 24, 2023 | Benesch Joseph | See Remarks | Sell(S) | 4K | $1.76 | $7K |
| Jul 24, 2023 | Maraoui Claude | President & CEO, Director | Sell(S) | 21K | $1.76 | $37K |
| Jul 21, 2023 | Toledano Miranda Jayne | Director | Grant(A) | 27K | — | $0 |
| Jul 21, 2023 | Smith Justin Adam | Director | Grant(A) | 27K | — | $0 |
| Jul 21, 2023 | Paley Jeffrey | Director | Grant(A) | 27K | — | $0 |
| Jul 21, 2023 | Herskowitz Neil | Director | Grant(A) | 27K | — | $0 |
| May 17, 2023 | Maraoui Claude | President & CEO, Director | Sell(S) | 24K | $1.34 | $33K |
| May 16, 2023 | Maraoui Claude | President & CEO, Director | Sell(S) | 20K | $1.25 | $25K |
| May 12, 2023 | Fortress Biotech, Inc. | 10% Owner | Other(J) | 50K | — | $0 |
| Feb 22, 2023 | Benesch Joseph | Interim CFO | Sell(S) | 3K | $1.97 | $5K |
| Feb 12, 2023 | Fortress Biotech, Inc. | 10% Owner | Other(J) | 50K | — | $0 |
| Nov 12, 2022 | Fortress Biotech, Inc. | 10% Owner | Other(J) | 50K | — | $0 |
| Oct 4, 2022 | De Paolantonio Ernest Robert | See Remarks | Sell(S) | 10K | $2.41 | $24K |
| Aug 12, 2022 | Fortress Biotech, Inc. | 10% Owner | Other(J) | 50K | — | $0 |
| Jul 21, 2022 | De Paolantonio Ernest Robert | Chief Financial Officer | Grant(A) | 150K | — | $0 |
| Jul 21, 2022 | Maraoui Claude | President & CEO, Director | Grant(A) | 300K | — | $0 |
| Jul 21, 2022 | Toledano Miranda Jayne | Director | Grant(A) | 14K | — | $0 |
| Jul 21, 2022 | Herskowitz Neil | Director | Grant(A) | 14K | — | $0 |
| Jul 21, 2022 | Paley Jeffrey | Director | Grant(A) | 14K | — | $0 |
| Jul 21, 2022 | Smith Justin Adam | Director | Grant(A) | 14K | — | $0 |
| Jul 21, 2022 | Rosenwald Lindsay A MD | Director | Grant(A) | 14K | — | $0 |
| May 12, 2022 | Fortress Biotech, Inc. | 10% Owner | Other(J) | 50K | — | $0 |
| Jan 14, 2022 | De Paolantonio Ernest Robert | Chief Financial Officer | Grant(A) | 120K | — | $0 |
| Jan 14, 2022 | Herskowitz Neil | Director | Grant(A) | 30K | — | $0 |
| Jan 14, 2022 | Smith Justin Adam | Director | Grant(A) | 30K | — | $0 |
| Jan 14, 2022 | Paley Jeffrey | Director | Grant(A) | 30K | — | $0 |
| Jan 14, 2022 | Toledano Miranda Jayne | Director | Grant(A) | 30K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Journey Medical Corp, SEC CIK 0001867066. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under DERM and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for DERM